OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
CGRP en migraña: de la fisiopatología a la terapéutica
Sonia Santos Lasaosa, R. Belvís, María L. Cuadrado, et al.
Neurología (2019) Vol. 37, Iss. 5, pp. 390-402
Open Access | Times Cited: 26
Sonia Santos Lasaosa, R. Belvís, María L. Cuadrado, et al.
Neurología (2019) Vol. 37, Iss. 5, pp. 390-402
Open Access | Times Cited: 26
Showing 1-25 of 26 citing articles:
Idiopathic intracranial hypertension: a step change in understanding the disease mechanisms
Andreas Yiangou, Susan P. Mollan, Alexandra J. Sinclair
Nature Reviews Neurology (2023) Vol. 19, Iss. 12, pp. 769-785
Closed Access | Times Cited: 27
Andreas Yiangou, Susan P. Mollan, Alexandra J. Sinclair
Nature Reviews Neurology (2023) Vol. 19, Iss. 12, pp. 769-785
Closed Access | Times Cited: 27
Is an “Epigenetic Diet” for Migraines Justified? The Case of Folate and DNA Methylation
Michał Fila, Cezary Chojnacki, Jan Chojnacki, et al.
Nutrients (2019) Vol. 11, Iss. 11, pp. 2763-2763
Open Access | Times Cited: 44
Michał Fila, Cezary Chojnacki, Jan Chojnacki, et al.
Nutrients (2019) Vol. 11, Iss. 11, pp. 2763-2763
Open Access | Times Cited: 44
Biodecoding: effective method as a preventive treatment of migraine in women
Lisbel Garzón Cutiño, Libertad Engracia Valdés Izquierdo, Damián Valdés Santiago
Deleted Journal (2025) Vol. 3, pp. 191-191
Closed Access
Lisbel Garzón Cutiño, Libertad Engracia Valdés Izquierdo, Damián Valdés Santiago
Deleted Journal (2025) Vol. 3, pp. 191-191
Closed Access
Celia Romero del Rincón, Alicia González‐Martínez, Sonia Quintas, et al.
European Journal of Neurology (2024) Vol. 31, Iss. 4
Open Access | Times Cited: 2
Managing and Preventing Migraine in the Emergency Department: A Review
Miguel A. Cortel‐LeBlanc, Serena L. Orr, Maeghan Dunn, et al.
Annals of Emergency Medicine (2023) Vol. 82, Iss. 6, pp. 732-751
Open Access | Times Cited: 5
Miguel A. Cortel‐LeBlanc, Serena L. Orr, Maeghan Dunn, et al.
Annals of Emergency Medicine (2023) Vol. 82, Iss. 6, pp. 732-751
Open Access | Times Cited: 5
Documento de consenso de la Sociedad Española de Neurología (SEN), Sociedad Española de Medicina de Familia y Comunitaria (SEMFYC), Sociedad de Medicina de Atención Primaria (SEMERGEN) y Asociación Española de Migraña y Cefalea (AEMICE) sobre el tratamiento de la migraña
R. Belvís, Pablo Irimia, Nuria González, et al.
Medicina Clínica (2024) Vol. 163, Iss. 4, pp. 208.e1-208.e10
Closed Access | Times Cited: 1
R. Belvís, Pablo Irimia, Nuria González, et al.
Medicina Clínica (2024) Vol. 163, Iss. 4, pp. 208.e1-208.e10
Closed Access | Times Cited: 1
A
Lisbel Garzón Cutiño, Libertad Engracia Valdés Izquierdo, Damián Valdés Santiago, et al.
Deleted Journal (2024) Vol. 2, pp. 99-99
Closed Access | Times Cited: 1
Lisbel Garzón Cutiño, Libertad Engracia Valdés Izquierdo, Damián Valdés Santiago, et al.
Deleted Journal (2024) Vol. 2, pp. 99-99
Closed Access | Times Cited: 1
Fracaso de un anticuerpo monoclonal anti-CGRP en el tratamiento de la migraña. ¿Tiene sentido probar otro?
Yolanda López-Moreno, María Victoria Castro-Sánchez, Lucía García-Trujillo, et al.
Revista de Neurología (2022) Vol. 75, Iss. 04, pp. 87-87
Open Access | Times Cited: 6
Yolanda López-Moreno, María Victoria Castro-Sánchez, Lucía García-Trujillo, et al.
Revista de Neurología (2022) Vol. 75, Iss. 04, pp. 87-87
Open Access | Times Cited: 6
Actualización de la Migraña
Andrea Solano Mora, Xinia Ramírez Vargas, Andrés Castillo
Revista Medica Sinergia (2020) Vol. 5, Iss. 4, pp. e447-e447
Open Access | Times Cited: 4
Andrea Solano Mora, Xinia Ramírez Vargas, Andrés Castillo
Revista Medica Sinergia (2020) Vol. 5, Iss. 4, pp. e447-e447
Open Access | Times Cited: 4
Migraine treatment consensus document of the Spanish Society of Neurology (SEN), Spanish Society of Family and Community Medicine (SEMFYC), Society of Primary Care Medicine (SEMERGEN) and Spanish Association of Migraine and Headache (AEMICE) on migraine treatment
R. Belvís, Pablo Irimia, Nuria González, et al.
Medicina Clínica (English Edition) (2024) Vol. 163, Iss. 4, pp. 208.e1-208.e10
Closed Access
R. Belvís, Pablo Irimia, Nuria González, et al.
Medicina Clínica (English Edition) (2024) Vol. 163, Iss. 4, pp. 208.e1-208.e10
Closed Access
Impact of Biodecoding on disability associated with migraine
Lisbel Garzón Cutiño, Libertad Engracia Valdés Izquierdo, Damián Valdés Santiago
Multidisciplinar (2024) Vol. 3, pp. 37-37
Closed Access
Lisbel Garzón Cutiño, Libertad Engracia Valdés Izquierdo, Damián Valdés Santiago
Multidisciplinar (2024) Vol. 3, pp. 37-37
Closed Access
Calcitonin gene-related peptide inhibits neuronal apoptosis in heatstroke rats via PKA/p-CREB pathway
Jie Zhu, Yahong Chen, Jing-Jing Ji, et al.
Chinese Journal of Traumatology (2023) Vol. 27, Iss. 1, pp. 18-26
Open Access | Times Cited: 1
Jie Zhu, Yahong Chen, Jing-Jing Ji, et al.
Chinese Journal of Traumatology (2023) Vol. 27, Iss. 1, pp. 18-26
Open Access | Times Cited: 1
Inequity of access to new migraine treatments
Pablo Irimia, R. Belvís, N. González-García, et al.
Neurología (English Edition) (2023) Vol. 38, Iss. 8, pp. 599-600
Open Access | Times Cited: 1
Pablo Irimia, R. Belvís, N. González-García, et al.
Neurología (English Edition) (2023) Vol. 38, Iss. 8, pp. 599-600
Open Access | Times Cited: 1
Reducción de los niveles plasmáticos de CGRP en pacientes con migraña tratados con erenumab o galcanezumab
Daniel A. Garcı́a-Estévez, A. Juanatey-García, Jorge Rodríguez-Garrido, et al.
Revista de Neurología (2024) Vol. 78, Iss. 10, pp. 293-293
Closed Access
Daniel A. Garcı́a-Estévez, A. Juanatey-García, Jorge Rodríguez-Garrido, et al.
Revista de Neurología (2024) Vol. 78, Iss. 10, pp. 293-293
Closed Access
Spinal manipulations for migraine: an updated systematic review and meta-analysis of randomized clinical trials
Paul Posadzki, A Klimek, Edzard Ernst
Systematic Reviews (2024) Vol. 13, Iss. 1
Open Access
Paul Posadzki, A Klimek, Edzard Ernst
Systematic Reviews (2024) Vol. 13, Iss. 1
Open Access
Inequidad de acceso a los nuevos tratamientos para la migraña
Pablo Irimia, R. Belvís, N. García González, et al.
Neurología (2022) Vol. 38, Iss. 8, pp. 599-600
Open Access | Times Cited: 2
Pablo Irimia, R. Belvís, N. García González, et al.
Neurología (2022) Vol. 38, Iss. 8, pp. 599-600
Open Access | Times Cited: 2
Recomendaciones de la Asociación Colombiana de Neurología para el uso de anticuerpos monoclonales antiCGRP en la profilaxis de migraña
Oscar Enrique Pradilla-Vesga, José David Martinez, Mauricio Rueda-Sánchez, et al.
Acta neurológica colombiana (2022) Vol. 38, Iss. 1 Supl 1, pp. 1-22
Open Access | Times Cited: 1
Oscar Enrique Pradilla-Vesga, José David Martinez, Mauricio Rueda-Sánchez, et al.
Acta neurológica colombiana (2022) Vol. 38, Iss. 1 Supl 1, pp. 1-22
Open Access | Times Cited: 1
Experiencia clínica con erenumab durante el primer año de tratamiento
Alicia Caso-González, Claudia Leralta-González, V. Sanz-Alonso, et al.
Revista de Neurología (2021) Vol. 74, Iss. 01, pp. 8-8
Closed Access | Times Cited: 1
Alicia Caso-González, Claudia Leralta-González, V. Sanz-Alonso, et al.
Revista de Neurología (2021) Vol. 74, Iss. 01, pp. 8-8
Closed Access | Times Cited: 1
Migraña
E. Jara Jiménez, M.P. Navarro Pérez, A. López-Bravo, et al.
Medicine - Programa de Formación Médica Continuada Acreditado (2023) Vol. 13, Iss. 71, pp. 4153-4165
Closed Access
E. Jara Jiménez, M.P. Navarro Pérez, A. López-Bravo, et al.
Medicine - Programa de Formación Médica Continuada Acreditado (2023) Vol. 13, Iss. 71, pp. 4153-4165
Closed Access
Nuevos tratamientos para la migraña
Eva María Calvo Martínez, Silvia Copetti Fanlo, Fernando José Espada Oliván, et al.
FMC - Formación Médica Continuada en Atención Primaria (2023) Vol. 30, Iss. 4, pp. 194-204
Closed Access
Eva María Calvo Martínez, Silvia Copetti Fanlo, Fernando José Espada Oliván, et al.
FMC - Formación Médica Continuada en Atención Primaria (2023) Vol. 30, Iss. 4, pp. 194-204
Closed Access
[Translated article] Consensus recommendations on the preventive treatment of migraine
Miguel Ángel Calleja‐Hernández, Ángel Luis Guerrero Peral, Pablo Irimia, et al.
Farmacia Hospitalaria (2023) Vol. 47, Iss. 6, pp. T246-T253
Open Access
Miguel Ángel Calleja‐Hernández, Ángel Luis Guerrero Peral, Pablo Irimia, et al.
Farmacia Hospitalaria (2023) Vol. 47, Iss. 6, pp. T246-T253
Open Access
Actualización en el tratamiento de la migraña: péptido relacionado con el gen de la calcitonina (CGRP)
Stephanie María Ferllini Montealegre, María Fernanda Miranda Muñoz, Allan David Picado Álvarez
Revista Medica Sinergia (2019) Vol. 4, Iss. 10, pp. e283-e283
Open Access
Stephanie María Ferllini Montealegre, María Fernanda Miranda Muñoz, Allan David Picado Álvarez
Revista Medica Sinergia (2019) Vol. 4, Iss. 10, pp. e283-e283
Open Access
Erenumab for the treatment of chronic resistant migraine
Almudena Layos-Romero, Alberto Andrés López, Laura Rojas Bartolomé
Medicina Clínica (English Edition) (2022) Vol. 158, Iss. 2, pp. 96-97
Closed Access
Almudena Layos-Romero, Alberto Andrés López, Laura Rojas Bartolomé
Medicina Clínica (English Edition) (2022) Vol. 158, Iss. 2, pp. 96-97
Closed Access
Eficacia y seguridad del fremanezumab según datos de la vida real
Jésica García Ull
Kranion (2022) Vol. 17, Iss. 2
Open Access
Jésica García Ull
Kranion (2022) Vol. 17, Iss. 2
Open Access
Mab-Mig: Registry of the Spanish Neurological Society of Erenumab for Migraine Prevention. Three-Months Results
R. Belvís, Pablo Irimia, Patricia Pozo‐Rosich, et al.
Research Square (Research Square) (2021)
Open Access
R. Belvís, Pablo Irimia, Patricia Pozo‐Rosich, et al.
Research Square (Research Square) (2021)
Open Access
